A great deal of nanocarriers have been applied to induce
ferroptosis
in cancer research, yet there are limited examples of nanocarrier
formulations to rescue ferroptosis, which can be applied to neurodegeneration,
inflammation, liver damage, kidney disease, and more. Here, we present
the synthesis, characterization, and in vitro evaluation of pH-responsive,
core-cross-linked micelle (CCM) ferrostatin-1 (Fer-1) conjugates with
amine, valproic acid, and biotin surface chemistries. Fer-1 release
from stable and defined CCM Fer-1 conjugates was quantified, highlighting
the sustained release for 24 h. CCM Fer-1 conjugates demonstrated
excellent ferroptosis rescue by their antilipid peroxidation activity
in a diverse set of cell lines in vitro. Additionally, CCMs showed
tunable cell association in SH-SY5Y and translocation across an in
vitro blood–brain barrier (BBB) model, highlighting potential
brain disease applications. Overall, here, we present a polymeric
Fer-1 delivery system to enhance Fer-1 action, which could help in
improving Fer-1 action in the treatment of ferroptosis-related diseases.